Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vassiliki P Grimanelli"'
Autor:
Katerina C, Nastou, Eleftheria G, Karataraki, Nikos C, Papandreou, Anna-Isavella G, Rerra, Vassiliki P, Grimanelli, Ilias, Maglogiannis, Stavros J, Hamodrakas, Vassiliki A, Iconomidou
Publikováno v:
Advances in experimental medicine and biology. 1194
Monoclonal antibodies (mAbs) constitute a promising class of therapeutics, since ca. 25% of all biotech drugs in development are mAbs. Even though their therapeutic value is now well established, human- and murine-derived mAbs do have deficiencies, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18ba10509ef1620828375e9515cba2c0
https://pubmed.ncbi.nlm.nih.gov/32468552
https://pubmed.ncbi.nlm.nih.gov/32468552
Autor:
Eleftheria G Karataraki, Nikos C. Papandreou, Katerina C. Nastou, Vassiliki A. Iconomidou, Stavros J. Hamodrakas, Ilias Maglogiannis, Anna-Isavella G Rerra, Vassiliki P Grimanelli
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783030326210
Monoclonal antibodies (mAbs) constitute a promising class of therapeutics, since ca. 25% of all biotech drugs in development are mAbs. Even though their therapeutic value is now well established, human- and murine-derived mAbs do have deficiencies, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::922e3cb75394bfbefe267c7a2fa3944a
https://doi.org/10.1007/978-3-030-32622-7_34
https://doi.org/10.1007/978-3-030-32622-7_34
